Posted on 6/1/2021
Europe Biosimilar Insulin Glargine & Lispro Market, By End User (Type 1 Diabetes and Type 2 Diabetes),By Country (Germany, United Kingdom, France, Italy, Spain, Russia, Turkey, Poland, The Netherlands, Austria & Rest of Europe), Competition, Forecast
New York, Feb. 05, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Europe Biosimilar Insulin Glargine & Lispro Market, By End User,By Country, Competition, Forecast & Opportunities, 2024" - https://www.reportlinker.com/p05843936/?utm_source=GNW
Europe biosimilar insulin glargine and lispro market is projected to reach $ 1.9 billion by 2024...